XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

CALGARY, Alberta, Oct. 18, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovat

By: financialpost.com

Oct 18 2024
105
14437 Views

A.G.P./Alliance Global Partners acted as sole placement agent for the Offering. Read More

ThreeD Capital Inc. Disposes of Securities of Birchtree Investments Ltd.

PIMCO Canada Announces Special Meeting Details for the Proposed Mergers of Certain Closed-end Funds

Fairfax Donates US$1 Million to Relief Efforts for Hurricanes Helene and Milton

Tintina Announces Resignation of Director and Appointment of New Director

News Release for Early Warning Report Regarding Dundee Corporation

Village Farms International Provides Update on Nasdaq Listing

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Zefiro Methane Corp. Highlights Commercial Momentum on Live Investor Call

Howard Levitt: Cheating on your expenses and your resume still a recipe for getting fired

Imperial to hold 2024 Third Quarter Earnings Call

TILT Holdings Announces the Departure of its Chief Revenue Officer

Judge delays order in antitrust case requiring Google to open up its app store

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Related